CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-15 | Wang Xiaodong Director | Sale | −395 | $202.05 | $80K | 0 |
| 2019-11-15 | Wu Xiaobin President & GM China | Sale | −1,000 | $202.05 | $202K | 0 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −800 | $191.03 | $153K | 9,200 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −2,500 | $192.19 | $480K | 6,700 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −2,200 | $193.04 | $425K | 4,500 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −704 | $194.12 | $137K | 3,796 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −1,900 | $195.14 | $371K | 1,896 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −300 | $195.86 | $59K | 1,596 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −100 | $196.87 | $20K | 1,496 |
| 2019-11-14 | Wang Xiaodong Director | Sale | −2,605 | $193.57 | $504K | 395 |
| 2019-11-13 | Wang Xiaodong Director | Other disposition | −50 | 4,903,998 | ||
| 2019-11-13 | Wang Xiaodong Director | Grant or award | +50 | 50 | ||
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Option exercise | +4,000 | $41.01 | $164K | 4,000 |
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Sale | −200 | $187.38 | $37K | 3,800 |
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Sale | −1,500 | $188.71 | $283K | 2,300 |
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Sale | −1,892 | $189.56 | $359K | 408 |
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Sale | −208 | $190.32 | $40K | 200 |
| 2019-11-05 | Chen Timothy Yung-Cheng Director | Option exercise · Share Option (Right to Buy) | +52,000 | 65,988 | ||
| 2019-11-04 | Huang Jane CMO, Hematology | Option exercise | +32,900 | $29.49 | $970K | 32,900 |
| 2019-11-04 | Huang Jane CMO, Hematology | Sale | −4,569 | $189.08 | $864K | 28,331 |
Page 98 of 99 · 1,972 trades